eMedicine Specialties > Physical Medicine and Rehabilitation > Lower Limb Musculoskeletal Conditions

Achilles Tendon Injuries and Tendonitis: Treatment & Medication

Author: Anthony J Saglimbeni, MD, Staff Physician, Family Practice Residency, President, South Bay Sports and Preventive Medicine Associates; Private Practice; Team Internist, San Francisco Giants; Team Internist, West Valley College; Team Physician, Bellarmine College Prep; Team Physician, Presentation High School
Coauthor(s): Christian J Fulmer, DO, Private Practice in Sports and Family Medicine; Team Physician, Valley Christian High School
Contributor Information and Disclosures

Updated: Oct 14, 2009

Treatment

Rehabilitation Program

Physical Therapy

  • Achilles tendon rupture
    • Physical therapy for a patient with an Achilles tendon rupture focuses primarily on postoperative care.
    • Therapy usually is initiated at 6-8 weeks following surgery with simple active range of motion (ROM) exercises, 20 minutes twice daily. The patient then progresses to isometric ankle exercises with knee and hip strengthening. Eventually toe raises and progressive resistance exercises are added, culminating with proprioceptive training. At 12 weeks, devices may be utilized to enhance ROM passively with a realistic goal for full range of motion at 6 months.
  • Achilles tendonitis
    • Physical therapy for patients with Achilles tendonitis consists of several stages. The initial goal of physical therapy is to control the inflammation.
    • In the first and part of the second phase, pain is used to guide the intensity of exercise. Active ankle dorsiflexion with gentle calf stretching is performed.
    • In the intermediate phase, strengthening replaces active ROM, and neuromuscular control programs are initiated.
    • In the third phase of rehabilitation, progressive stress is applied under good control to allow the collagen to form appropriately. As pain resolves, perform aggressive stretching and active resisted motion.
    • One therapeutic modality that has gained interest is the performance of eccentric loading exercises. A review article demonstrated that this modality improves pain in patients with chronic Achilles tendinopathy. Further research is ongoing in an effort to clarify the exact role of eccentric training in tendinopathies.
    • Cryotherapy is useful in all of these stages. Physical modalities, such as ultrasound and electrical stimulation, also are useful to decrease pain and inflammation.

Medical Issues/Complications

  • Medical therapy for a patient with an Achilles tendon rupture consists of rest, pain control, serial casting, and rehabilitation to maximize function. Ongoing debate surrounds the issue of whether medical or surgical therapy is more appropriate for this injury.
    • Activity modification for a ruptured Achilles tendon requires crutch ambulation without weight bearing. Once initiated, serial casting dictates the activity level.
    • Orthotic therapy is useful after serial casting. Serial casting usually results in some Achilles contracture, and heel lifts are used after casting. Depending on the degree of shortening and rate and aggressiveness of physical therapy, initiate use of 1-2 inch heel lifts with gradual weekly or biweekly adjustment directed toward weaning the patient off of the heel lifts.
    • Casting is one way to treat Achilles tendon rupture. Overall healing rates are similar to those of surgical reanastomosis, yet the return-to-activity benefits of surgery are debated. Nonetheless, this is viable therapy, especially for more sedentary patients and older persons. The initial cast applied is a long-leg cast with some knee flexion and ankle plantar flexion to allow free edges of the Achilles to approximate. The cast is changed in series, decreasing the plantar flexion and eventually moving toward short-leg casts in a neutral ankle position. This treatment lasts 6-12 weeks.
    • High-energy extracorporeal shock wave therapy has shown promise as a treatment for insertional Achilles tendinopathy. One study demonstrated that a single treatment was more effective than traditional conservative treatment in improving pain and enabling patients to return to their activities.
    • Medical therapy for Achilles tendon rupture is concerned primarily with pain control; some of the remedies are outlined below (see Medication).
  • Medical therapy for Achilles tendonitis includes activity modification, orthotic therapy, physical therapy, and analgesic anti-inflammatory medication.1,2,3
    • Activity modification for Achilles tendonitis requires that the patient abstain from aggravating activities with a minimum of rest to preserve overall fitness. This may include modification of the offending activity, such as avoiding running uphill or on uneven surfaces. If the athlete is a cyclist, proper saddle adjustment can help to reduce symptoms.
    • Orthotic therapy in Achilles tendonitis also consists of the use of heel lifts; however, lifts usually are not used to the extent utilized after serial casting for rupture. The goal is eventually to use conventional shoes. Orthotic devices usually are used bilaterally to prevent a gait imbalance. Since overpronation and cavus foot deformities can cause tendonitis, custom orthotics to correct overpronation or shock absorbing shoes for cavus deformities can alleviate pain as well.
    • Casting is an option for resistant Achilles tendonitis. This is the ultimate form of rest for the Achilles tendon and is usually a last resort for this condition. A cast boot can be used.
    • Medical therapy for Achilles tendonitis includes pain control and use of anti-inflammatory medications, some of which are detailed below (see Medication).

Surgical Intervention

  • Surgical techniques are varied and usually involve reapproximation of the torn ends of the Achilles tendon, sometimes reinforced by the gastrocnemius-soleus aponeurosis or plantaris tendon. Controversy exists as to whether surgical or conservative treatment is preferable.4
  • Advocates of conservative treatment cite the similar results between conservative and surgical treatment when looking at ROM, strength, power, and functional levels as a reason for avoiding surgery. Surgical advocates argue that full function is achieved more quickly with surgical therapy than with conservative therapy, especially for athletic individuals. The surgical approach is supported by a lower rate of rerupture, greater postoperative power, and low infection rate. Finally, conservative clinicians state that, with early application and prolonged duration of casting, the rerupture rate is decreased significantly.
  • Surgery has often been applied in cases of recalcitrant Achilles tendonitis. Techniques include peritenon stripping and debridement of pathologic tissue to create an acute and better healing wound. Aftercare involves prolonged casting, and there is concern that the immobilization caused by casting is as curative as the surgical technique. Nonetheless, surgery is usually a last resort in treatment of tendonitis.
  • While the reasons are not precisely known, surgery tends not to be as successful in nonathletic individuals with chronic Achilles tendinopathy. Nonathletic patients tend to have a more prolonged recovery, a greater risk of complications, and they are more likely to need further surgery than athletic individuals.

Consultations

Consultation is helpful when a DVT is diagnosed.

Medication

Two major categories of drugs used in Achilles tendon rupture and Achilles tendonitis are analgesics, both opioid and nonopioid, and nonsteroidal anti-inflammatory agents (NSAIDs). Consider side effects and patient profiles when choosing medications. Acetaminophen can result in liver damage. Opioids can result in gastrointestinal distress, constipation, and sedation and have addictive potential. NSAIDs can result in gastrointestinal upset, gastrointestinal bleeding, renal damage, and impaired coagulation. New generation of COX-2 inhibiting NSAIDs may have fewer side effects. Currently, the only available COX-2 drug is celecoxib.

Analgesics

Pain control is essential to quality patient care. Analgesics ensure patient comfort and have sedating properties, which are beneficial for patients who have sustained trauma or have sustained injuries.


Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)

DOC for pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who are taking oral anticoagulants.

Adult

500-1300 mg PO q6h prn

Pediatric

Not established

Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Hepatotoxicity possible in chronic alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; APAP is contained in many OTC products and combined use with these products may result in cumulative APAP doses exceeding recommended maximum dose

Opioid analgesics

Control of moderate to severe pain.


Hydrocodone and acetaminophen (Vicodin, Lorcet, Lortab)

Drug combination indicated for moderate to severe pain.

Adult

1-2 tabs PO q6h prn

Pediatric

Not established

Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants

Documented hypersensitivity; high altitude cerebral edema (HACE) or elevated intracranial pressure (ICP)

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Tablets contain metabisulfite which may cause hypersensitivity; caution in patients dependent on opiates since this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction

Nonsteroidal anti-inflammatory drugs

Have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclo-oxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell membrane functions.


Naproxen (Naprosyn, Aleve, Naprelan, Anaprox)

For relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclo-oxygenase, which results in a decrease of prostaglandin synthesis.

Adult

500 mg PO bid prn

Pediatric

Not established

Coadministration with aspirin increases risk of inducing serious NSAID-related side effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Pregnancy category D in third trimester; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug

Cyclo-oxygenase II inhibitors

Control of pain and inflammation, especially in cases of contraindication to conventional anti-inflammatories. Although increased cost can be a negative factor, the incidence of costly and potentially fatal GI bleeds is clearly less with COX-II inhibitors than with traditional NSAIDs. Ongoing analysis of cost avoidance of GI bleeds will further define the populations that will find COX-II inhibitors the most beneficial.


Celecoxib (Celebrex)

Inhibits primarily COX-2. COX-2 is considered an inducible isoenzyme, induced during pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited thus GI toxicity may be decreased. Seek lowest dose of celecoxib for each patient.

Adult

200-400 mg/d PO or divided bid

Pediatric

Not established

Coadministration with fluconazole may cause increase in celecoxib plasma concentrations because of inhibition of celecoxib metabolism; coadministration of celecoxib with rifampin may decrease celecoxib plasma concentrations

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May cause fluid retention and peripheral edema; caution in compromised cardiac function, hypertension, conditions predisposing to fluid retention; caution in severe heart failure and hyponatremia because may deteriorate circulatory hemodynamics; NSAIDs may mask usual signs of infection; caution in the presence of existing controlled infections; evaluate therapy when symptoms or lab results suggest liver dysfunction

More on Achilles Tendon Injuries and Tendonitis

Overview: Achilles Tendon Injuries and Tendonitis
Differential Diagnoses & Workup: Achilles Tendon Injuries and Tendonitis
Treatment & Medication: Achilles Tendon Injuries and Tendonitis
Follow-up: Achilles Tendon Injuries and Tendonitis
References
Further Reading

References

  1. Grigg NL, Stevenson NJ, Wearing SC, et al. Incidental walking activity is sufficient to induce time-dependent conditioning of the Achilles tendon. Gait Posture. Oct 5 2009;[Medline].

  2. Henriksen M, Aaboe J, Bliddal H, et al. Biomechanical characteristics of the eccentric Achilles tendon exercise. J Biomech. Sep 21 2009;[Medline].

  3. Gardin A, Movin T, Svensson L, et al. The long-term clinical and MRI results following eccentric calf muscle training in chronic Achilles tendinosis. Skeletal Radiol. Sep 23 2009;[Medline].

  4. Wegrzyn J, Luciani JF, Philippot R, et al. Chronic Achilles tendon rupture reconstruction using a modified flexor hallucis longus transfer. Int Orthop. Aug 21 2009;[Medline].

  5. Silbernagel KG, Nilsson-Helander K, Thomee R, et al. A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture. Knee Surg Sports Traumatol Arthrosc. Aug 19 2009;[Medline].

  6. Hawkins D, Lum C, Gaydos D, et al. Dynamic creep and pre-conditioning of the Achilles tendon in-vivo. J Biomech. Sep 15 2009;[Medline].

  7. Adler RS, Finzel KC. The Complementary Roles of MR Imaging and Ultrasound of Tendons. Radiol Clin North Am. Jul 2005;43(4):771-807. [Medline].

  8. Alvarez-Nemegyei J, Canoso JJ. Heel pain: diagnosis and treatment, step by step. Cleve Clin J Med. May 2006;73(5):465-71.

  9. Brown DE. Ankle and leg injuries. In: Mellion MB, Walsh M, Shelton GL, eds. The Team Physician's Handbook, 3rd ed. Philadelphia, Pa: Hanley & Belfus; 2002:. 518-9.

  10. Canale T. Rupture of muscles and tendons. In: Campbell's Operative Orthopaedics. Vol 10. St. Louis, Mo: Mosby; 2003:. 2458-2468.

  11. Furia JP. High-energy extracorporeal shock wave therapy as a treatment for insertional Achilles tendinopathy. Am J Sports Med. May 2006;34(5):733-40.

  12. Humble RN, Nugent LL. Achilles'' tendonitis. An overview and reconditioning model. Clin Podiatr Med Surg. Apr 2001;18(2):233-54. [Medline].

  13. Johnson MD. Physiology of musculoskeletal growth. In: Essentials of Sports Medicine. Vol 1. St. Louis, Mo: Mosby; 1997:. 534-8.

  14. Kingma JJ, de Knikker R, Wittink HW. Eccentric overload training in patients with a chronic Achilles tendinopathy: a systematic review. Br J Sports Med. Oct 11 2006.

  15. Maffulli N, Testa V, Capasso G. Surgery for chronic Achilles tendinopathy yields worse results in nonathletic patients. Clin J Sport Med. Mar 2006;16(2):123-8.

  16. Pedowitz RA, Saglimbeni AJ. The leg. In: Safran MR, McKeag DB, Van Camp SP, eds. Manual of Sports Medicine. Vol 1. Philadelphia, Pa: Lippincott-Raven; 1998:. 460-6.

  17. Taunton J, Smith C, Magee DJ. Leg, foot and ankle injuries. In: Athletic Injuries and Rehabilitation. Vol 1. Philadelphia, Pa: WB Saunders; 1996:. 736-9.

  18. Tomczak RL. Surgery of the Achilles'' tendon. Clin Podiatr Med Surg. Apr 2001;18(2):255-71, vi. [Medline].

  19. Ufberg J, Harrigan RA, Cruz T, Perron AD. Orthopedic pitfalls in the ED: Achilles tendon rupture. Am J Emerg Med. Nov 2004;22(7):596-600.

Further Reading

Clinical guidelines:
Ankle & foot (acute & chronic). Work Loss Data Institute - Public For Profit Organization. 2003 (revised 2008 Apr 15). 152 pages. NGC:006552

Clinical trials:
Acute Achilles Repair With or Without OrthADAPT Augmentation

Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer

Keywords

Achilles tendon, Achilles tendonitis, Achilles tendon rupture, Achilles tendinitis, Achilles tendon surgery, Achilles tendon pain, Achilles tendon injury, Achilles tendon treatment, Achilles tendon tear

Contributor Information and Disclosures

Author

Anthony J Saglimbeni, MD, Staff Physician, Family Practice Residency, President, South Bay Sports and Preventive Medicine Associates; Private Practice; Team Internist, San Francisco Giants; Team Internist, West Valley College; Team Physician, Bellarmine College Prep; Team Physician, Presentation High School
Disclosure: Nothing to disclose.

Coauthor(s)

Christian J Fulmer, DO, Private Practice in Sports and Family Medicine; Team Physician, Valley Christian High School
Christian J Fulmer, DO is a member of the following medical societies: American Academy of Family Physicians, American Academy of Osteopathy, American Medical Society for Sports Medicine, and American Osteopathic Association
Disclosure: Nothing to disclose.

Medical Editor

Robert E Windsor, MD, FAAPMR, FAAEM, FAAPM, President and Director, Georgia Pain Physicians, PC; Clinical Associate Professor, Department of Physical Medicine and Rehabilitation, Emory University School of Medicine
Robert E Windsor, MD, FAAPMR, FAAEM, FAAPM is a member of the following medical societies: American Academy of Pain Medicine, American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, American Medical Association, International Association for the Study of Pain, Physiatric Association of Spine, Sports and Occupational Rehabilitation, and Texas Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Michael T Andary, MD, MS, Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine
Michael T Andary, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists
Disclosure: allergan Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Consuelo T Lorenzo, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Alegent Health Care, Immanuel Rehabilitation Center
Consuelo T Lorenzo, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.